Importer of Controlled Substances; Notice of Registration, 9589 [E8-3174]
Download as PDF
9589
Federal Register / Vol. 73, No. 35 / Thursday, February 21, 2008 / Notices
64681), JFC Technologies LLC., 100
West Main Street, P.O. Box 669, Bound
Brook, New Jersey 08805, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Meperidine intermediate-B (9233), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
basic class of controlled substance for
the production of controlled substances
for clinical trials, research, analytical
purposes, and distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
JFC Technologies LLC. to import the
basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated JFC
Technologies LLC. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–3181 Filed 2–20–08; 8:45 am]
Drug Enforcement Administration
pwalker on PROD1PC71 with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 5, 2007
and published in the Federal Register
on November 16, 2007, (72 FR 64674),
Aptuit, 10245 Hickman Mills Drive,
Kansas City, Missouri 64137, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Marihuana (7360), a basic class of
controlled substance listed in
schedule I.
Jkt 214001
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Importer of Controlled Substances;
Notice of Application
DEPARTMENT OF JUSTICE
16:34 Feb 20, 2008
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–3174 Filed 2–20–08; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
VerDate Aug<31>2005
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form for packaging for a clinical trial
study.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Aptuit to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Aptuit to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a registration under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title 21
Code of Federal Regulations (CFR),
1301.34(a), this is notice that on January
10, 2008, Sigma Aldrich Manufacturing
LLC., 3500 Dekalb Street, St. Louis,
Missiouri 63118, made application to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedule I and II:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
N-Benzylpiperazine (BZP) (7493)
Trifluoromethylphenyl Piperazine
(7494).
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium powdered (9639) ..............
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
E:\FR\FM\21FEN1.SGM
21FEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Agencies
[Federal Register Volume 73, Number 35 (Thursday, February 21, 2008)]
[Notices]
[Page 9589]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3174]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated November 5, 2007 and published in the Federal
Register on November 16, 2007, (72 FR 64674), Aptuit, 10245 Hickman
Mills Drive, Kansas City, Missouri 64137, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as an
importer of Marihuana (7360), a basic class of controlled substance
listed in schedule I.
The company plans to import a finished pharmaceutical product
containing cannabis extracts in dosage form for packaging for a
clinical trial study.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Aptuit to import the basic class of controlled
substance is consistent with the public interest and with United States
obligations under international treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA has investigated Aptuit to
ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and
958(a), and in accordance with 21 CFR 1301.34, the above named company
is granted registration as an importer of the basic class of controlled
substance listed.
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-3174 Filed 2-20-08; 8:45 am]
BILLING CODE 4410-09-P